Thiazolidinedione use and risk of parkinson’s disease in patients with type 2 diabetes mellitus

HIGHLIGHTS

• who: Houyu Zhao from the reduce the future incidence of PD in China have published the paper: Thiazolidinedione use and risk of Parkinsonu2019s disease in patients with type 2 diabetes mellitus, in the Journal: (JOURNAL) of December/31,/2021
• what: The authors applied an active-comparator new-user (ACNU) design using AGIs which were another class of commonly used second-line hypoglycemic drugs in the study population27 as the comparator, with a rich set of potential confounders, including lifestyle factors and disease severity measures, thus mitigating time-related bias and confounding by indication25,28. In . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.